F Boury

555 total citations
4 papers, 28 citations indexed

About

F Boury is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, F Boury has authored 4 papers receiving a total of 28 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 1 paper in Nephrology. Recurrent topics in F Boury's work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Biochemical and Molecular Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). F Boury is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Biochemical and Molecular Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). F Boury collaborates with scholars based in Canada. F Boury's co-authors include L Giroux, G Jean, Pierre Daloze, J Corman and André Trouet and has published in prestigious journals such as Journal of Surgical Research and PubMed.

In The Last Decade

F Boury

3 papers receiving 28 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Boury Canada 3 14 6 6 5 4 4 28
Alma Hiller Germany 3 39 2.8× 15 2.5× 5 0.8× 7 1.4× 7 1.8× 3 74
Catalina Martín Cleary Spain 1 22 1.6× 10 1.7× 3 0.5× 2 0.4× 10 2.5× 2 42
Federico Pantellini Italy 6 11 0.8× 8 1.3× 3 0.5× 1 0.2× 5 1.3× 9 54
Andrea Campo Italy 3 14 1.0× 3 0.5× 8 1.3× 2 0.4× 7 1.8× 6 41
Wu Qing China 2 17 1.2× 5 0.8× 8 1.3× 2 0.4× 1 0.3× 2 31
Fabio Lizzi Germany 3 23 1.6× 3 0.5× 16 2.7× 3 0.6× 2 0.5× 3 40
Rebecca Hudson Australia 4 31 2.2× 6 1.0× 10 1.7× 15 3.0× 5 1.3× 8 47
Cecilia Riegel United States 5 6 0.4× 12 2.0× 1 0.2× 4 0.8× 6 1.5× 9 48
J Kryński Poland 3 7 0.5× 4 0.7× 3 0.5× 3 0.6× 11 2.8× 6 23
M. Ferrari Brazil 4 6 0.4× 10 1.7× 2 0.3× 1 0.2× 6 1.5× 8 40

Countries citing papers authored by F Boury

Since Specialization
Citations

This map shows the geographic impact of F Boury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Boury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Boury more than expected).

Fields of papers citing papers by F Boury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Boury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Boury. The network helps show where F Boury may publish in the future.

Co-authorship network of co-authors of F Boury

This figure shows the co-authorship network connecting the top 25 collaborators of F Boury. A scholar is included among the top collaborators of F Boury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Boury. F Boury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Giroux, L, et al.. (1984). Adriamycin and adriamycin-DNA nephrotoxicity in rats.. PubMed. 50(2). 190–6. 20 indexed citations
2.
Giroux, L, et al.. (1983). Comparative toxicity of adriamycin and adriamycin-DNA in rats.. PubMed. 42(1). 67–72. 3 indexed citations
3.
Boury, F, et al.. (1981). Modifications of glomerular fibrinolysis in human renal graft rejection. Journal of Surgical Research. 31(3). 253–258. 5 indexed citations
4.
Giroux, L, et al.. (1981). Effectiveness of the adriamycin-DNA complex in kidney allograft immunosuppression.. PubMed. 24(6). 597–600.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026